PUMA BIOTECHNOLOGY, INC. (PBYI) Current Income Tax Expense (Benefit)

PUMA BIOTECHNOLOGY, INC. Current Income Tax Expense (Benefit)

PUMA BIOTECHNOLOGY, INC. (PBYI) reported Current Income Tax Expense (Benefit) of $56.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-08-06

• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for the quarter ending 2026-06-30 was $56.00K, a 81.94% decline year-over-year.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for the quarter ending 2026-03-31 was $326.00K, a 11.26% increase year-over-year.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for the quarter ending 2025-12-31 was $424.00K, a 5200.00% increase year-over-year.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for the quarter ending 2025-09-30 was $399.00K, a 37.11% increase year-over-year.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for fiscal 2025 was $1.43M, a 58.97% increase from fiscal 2024.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for fiscal 2024 was $897.00K, a 17.17% decline from fiscal 2023.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for fiscal 2023 was $1.08M, a 138.02% increase from fiscal 2022.
• PUMA BIOTECHNOLOGY, INC. current income tax expense (benefit) for fiscal 2022 was $455.00K, a 40.43% increase from fiscal 2021.